Literature DB >> 23541230

Robotic retroperitoneal transvaginal natural orifice translumenal endoscopic surgery (NOTES) nephrectomy: feasibility study in a cadaver model.

Humberto Laydner1, Riccardo Autorino, Wahib Isac, Ali Khalifeh, Kamol Panumatrassamee, Ahmad Kassab, Jean-Alexandre Long, Remi Eyraud, Emad Rizkala, Robert J Stein, Jihad H Kaouk.   

Abstract

OBJECTIVE: To evaluate the feasibility of pure robotic natural orifice translumenal endoscopic surgery (R-NOTES) nephrectomy.
METHODS: Two R-NOTES nephrectomy approaches were attempted in 3 female cadavers. A single-port device was inserted through an incision in the posterior vaginal fornix. In the first approach, the peritoneal cavity was accessed in the lithotomy position. In the second approach, the retroperitoneum of 2 cadavers was accessed in the prone jackknife position. The ureter was identified and followed cranially. The hilum was stapled and the kidney was dissected. The specimen was extracted into a bag. The incision was closed with an open approach.
RESULTS: The first approach was not possible because of collision of the robotic arms against the legs and limited bowel retraction. After modifying the approach, a right transvaginal R-NOTES retroperitoneal nephrectomy was successfully completed, without adding extra ports. Time for setup was 128 minutes. Time to identify the ureter was 53 minutes. Dissection and control of the renal pedicle was completed in 21 minutes. Time to complete the dissection and extraction of the kidney was 36 minutes. Time to complete the procedure was 238 minutes. There were no injuries to retroperitoneal organs or vessels. In the third cadaver, there was rectal injury during the access. We were unable to complete the procedure because of the cadaver height.
CONCLUSION: Transvaginal R-NOTES nephrectomy is technically challenging but feasible in select female cadavers. Retroperitoneal approach in the prone jackknife position was instrumental in facilitating robotic access to the kidney through the vagina. Improvements in the technique and instrumentation are necessary to make this approach safe and reproducible.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23541230     DOI: 10.1016/j.urology.2012.11.083

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

Review 1.  Novel Technologies in Urologic Surgery: a Rapidly Changing Scenario.

Authors:  Giorgio Gandaglia; Peter Schatteman; Geert De Naeyer; Frederiek D'Hondt; Alexandre Mottrie
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

2.  On the suitability of Thiel cadavers for natural orifice transluminal endoscopic surgery (NOTES): surgical training, feasibility studies, and anatomical education.

Authors:  Andrea Porzionato; Lino Polese; Emanuele Lezoche; Veronica Macchi; Giovanni Lezoche; Gianfranco Da Dalt; Carla Stecco; Lorenzo Norberto; Stefano Merigliano; Raffaele De Caro
Journal:  Surg Endosc       Date:  2014-07-25       Impact factor: 4.584

Review 3.  Urological applications of natural orifice transluminal endoscopic surgery (NOTES).

Authors:  Mark D Tyson; Mitchell R Humphreys
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

4.  Development of targeted near-infrared imaging agents for prostate cancer.

Authors:  Xinning Wang; Steve S Huang; Warren D W Heston; Hong Guo; Bing-Cheng Wang; James P Basilion
Journal:  Mol Cancer Ther       Date:  2014-09-19       Impact factor: 6.261

5.  Transvaginal route for kidney extraction in laparoscopic donor nephrectomy.

Authors:  Ercument Gurluler; Ibrahim Berber; Ulkem Cakir; Alihan Gurkan
Journal:  JSLS       Date:  2014 Jul-Sep       Impact factor: 2.172

6.  Pure retroperitoneal natural orifice translumenal endoscopic surgery (NOTES) transvaginal nephrectomy using standard laparoscopic instruments: a safety and feasibility study in a porcine model.

Authors:  Dechao Wei; Yili Han; Mingchuan Li; Yongxing Wang; Yatong Chen; Yong Luo; Yongguang Jiang
Journal:  BMC Urol       Date:  2016-06-11       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.